farnesiferol-c and Colonic-Neoplasms

farnesiferol-c has been researched along with Colonic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for farnesiferol-c and Colonic-Neoplasms

Article	Year
Anticancer activity, calf thymus DNA and human serum albumin binding properties of Farnesiferol C from Journal of biomolecular structure & dynamics, 2019, Volume: 37, Issue:11 In this study, Farnesiferol C was introduced as an anti-colon cancer agent. Its cytotoxicity was investigated on two cancer cell lines, HCT116 and CT26, and mesenchymal stem cells (MSCs) as normal cells employing MTT assay. Moreover, Farnesiferol C interactions with ct-DNA and HSA were investigated by various techniques. The IC Topics: Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Coumarins; DNA; Ferula; Humans; Mesenchymal Stem Cells; Models, Molecular; Protein Binding; Protein Conformation; Rats; Serum Albumin, Human	2019

Article

Year

Anticancer activity, calf thymus DNA and human serum albumin binding properties of Farnesiferol C from

Journal of biomolecular structure & dynamics, 2019, Volume: 37, Issue:11

In this study, Farnesiferol C was introduced as an anti-colon cancer agent. Its cytotoxicity was investigated on two cancer cell lines, HCT116 and CT26, and mesenchymal stem cells (MSCs) as normal cells employing MTT assay. Moreover, Farnesiferol C interactions with ct-DNA and HSA were investigated by various techniques. The IC

Topics: Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Coumarins; DNA; Ferula; Humans; Mesenchymal Stem Cells; Models, Molecular; Protein Binding; Protein Conformation; Rats; Serum Albumin, Human

2019